Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea

  • Kim, Changhwan (Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine) ;
  • Kim, Younhee (Institute of Health and Environment, School of Public Health, Seoul National University) ;
  • Yang, Dong-Wook (Graduate School of Public Health, Seoul National University) ;
  • Rhee, Chin Kook (Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Sung Kyoung (Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Hwang, Yong-Il (Department of Internal Medicine, Hallym University Sacred Heart Hospital) ;
  • Park, Yong Bum (Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital) ;
  • Lee, Young Mok (GF Allergy Clinic) ;
  • Jin, Seonglim (Beautiful Breath Clinic) ;
  • Park, Jinkyeong (Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital) ;
  • Hahm, Cho-Rom (Department of Internal Medicine, Gwangmyeong Sungae Hospital) ;
  • Park, Chang-Han (Department of Internal Medicine, Sungae Hospital) ;
  • Park, So Yeon (A&A Clinic) ;
  • Jung, Cheol Kweon (Sanbon Yonsei Clinic) ;
  • Kim, Yu-Il (Department of Internal Medicine, Chonnam National University Hospital) ;
  • Lee, Sang Haak (Department of Internal Medicine, St. Paul's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Yoon, Hyoung Kyu (Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jin Hwa (Department of Internal Medicine, School of Medicine, Ewha Womans University) ;
  • Lim, Seong Yong (Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Yoo, Kwang Ha (Department of Internal Medicine, Konkuk University School of Medicine)
  • Received : 2018.04.03
  • Accepted : 2018.06.27
  • Published : 2019.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Understanding the burden of disease is important to establish cost-effective treatment strategies and to allocate healthcare resources appropriately. However, little reliable information is available regarding the overall economic burden imposed by chronic obstructive pulmonary disease (COPD) in Korea. Methods: This study is a multicenter observational research on the COPD burden in Korea. Total COPD costs were comprised of three categories: direct medical, direct non-medical, and indirect costs. For direct medical costs, institutional investigation was performed at 13 medical facilities mainly based on the claims data. For direct non-medical and indirect costs, site-based surveys were administered to the COPD patients during routine visits. Total costs were estimated using the COPD population defined in the recent report. Results: The estimated total costs were approximately 1,245 million US dollar (1,408 billion Korean won). Direct medical costs comprised approximately 20% of the total estimated costs. Of these, formal medical costs held more than 80%. As direct non-medical costs, nursing costs made up the largest percentage (39%) of the total estimated costs. Costs for COPD-related loss of productivity formed four fifths of indirect costs, and accounted for up to 33% of the total costs. Conclusion: This study shows for the first time the direct and indirect costs of COPD in Korea. The total costs were enormous, and the costs of nursing and lost productivity comprised approximately 70% of total costs. The results provide insight for an effective allocation of healthcare resources and to inform establishment of strategies to reduce national burden of COPD.

Keywords

References

  1. Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 2016;20:11-23. https://doi.org/10.5588/ijtld.15.0472
  2. Terzikhan N, Verhamme KM, Hofman A, Stricker BH, Brusselle GG, Lahousse L. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol 2016;31:785-92. https://doi.org/10.1007/s10654-016-0132-z
  3. Hwang YI, Park YB, Yoo KH. Recent trends in the prevalence of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis 2017;80:226-9. https://doi.org/10.4046/trd.2017.80.3.226
  4. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65. https://doi.org/10.1111/j.1440-1843.2011.01951.x
  5. Kim C, Yoo KH, Rhee CK, Yoon HK, Kim YS, Lee SW, et al. Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea. Int J Tuberc Lung Dis 2014;18:737-43. https://doi.org/10.5588/ijtld.13.0634
  6. Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 2014;11:163-70. https://doi.org/10.3109/15412555.2013.831061
  7. Lee JY, Chon GR, Rhee CK, Kim DK, Yoon HK, Lee JH, et al. Characteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: the KOrea COpd Subgroup Study Team Cohort. J Korean Med Sci 2016;31:553-60. https://doi.org/10.3346/jkms.2016.31.4.553
  8. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353-65. https://doi.org/10.2165/00019053-199304050-00006
  9. Kim EJ, Yoon SJ, Jo MW, Kim HJ. Measuring the burden of chronic diseases in Korea in 2007. Public Health 2013;127:806-13. https://doi.org/10.1016/j.puhe.2012.12.024
  10. Yoo KH, Ahn HR, Park JK, Kim JW, Nam GH, Hong SK, et al. Burden of respiratory disease in Korea: an observational study on allergic rhinitis, asthma, COPD, and rhinosinusitis. Allergy Asthma Immunol Res 2016;8:527-34. https://doi.org/10.4168/aair.2016.8.6.527
  11. Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis 2014;9:289-300. https://doi.org/10.2147/COPD.S57157
  12. Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med 2008;102:1744-52. https://doi.org/10.1016/j.rmed.2008.07.009
  13. Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respir Med 2008;102:92-101. https://doi.org/10.1016/j.rmed.2007.08.001
  14. Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:596-601. https://doi.org/10.1164/rccm.201211-2044OC
  15. Troosters T, Gosselink R, Janssens W, Decramer M. Exercise training and pulmonary rehabilitation: new insights and remaining challenges. Eur Respir Rev 2010;19:24-9. https://doi.org/10.1183/09059180.00007809
  16. Yoon HK, Park YB, Rhee CK, Lee JH, Oh YM; Committee of the Korean COPD Guideline 2014. Summary of the chronic obstructive pulmonary disease clinical practice guideline revised in 2014 by the Korean Academy of Tuberculosis and Respiratory Disease. Tuberc Respir Dis 2017;80:230-40. https://doi.org/10.4046/trd.2017.80.3.230
  17. Chung SM, Lee SY. Evaluation of appropriate management of chronic obstructive pulmonary disease in Korea: based on Health Insurance Review and Assessment Service (HIRA) claims. Tuberc Respir Dis 2017;80:241-6. https://doi.org/10.4046/trd.2017.80.3.241

Cited by

  1. CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition vol.14, 2019, https://doi.org/10.2147/copd.s228307
  2. Reducing chronic obstructive pulmonary disease mortality in Korea: early diagnosis matters vol.34, pp.6, 2019, https://doi.org/10.3904/kjim.2019.327
  3. Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India vol.4, pp.2, 2020, https://doi.org/10.1007/s41669-019-0172-x
  4. The Status and Influencing Factors of Respiratory System Diseases in Korean Farmers with Disease vol.31, pp.4, 2019, https://doi.org/10.7856/kjcls.2020.31.4.779
  5. The Association with COPD Readmission Rate and Access to Medical Institutions in Elderly Patients vol.16, 2021, https://doi.org/10.2147/copd.s302631
  6. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study vol.16, 2019, https://doi.org/10.2147/copd.s332151
  7. Updated view on the treatment of chronic obstructive pulmonary disease in Korea vol.64, pp.3, 2019, https://doi.org/10.5124/jkma.2021.64.3.225
  8. Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea vol.84, pp.2, 2019, https://doi.org/10.4046/trd.2020.0109
  9. Predicting long-term mortality with two different criteria of exercise-induced desaturation in COPD vol.182, 2019, https://doi.org/10.1016/j.rmed.2021.106393
  10. Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review vol.11, pp.1, 2019, https://doi.org/10.1186/s13561-021-00329-9